Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries

Published on Nov 8, 2017in Frontiers in Public Health
· DOI :10.3389/fpubh.2017.00295
Tanja Pekez-Pavlisko1
Estimated H-index: 1
Maja Račić3
Estimated H-index: 3
(University of East Sarajevo),
Srebrenka Kusmuk1
Estimated H-index: 1
(University of East Sarajevo)
Background: During the transition processes, the Western Balkan countries were affected by conflicts and transition related changes. Life expectancy in these countries is lower, while the mortality from non-communicable diseases is higher in comparison with western and northern parts of Europe. The primary aim of this study was to analyze the treatment possibilities for the most common non-communicable diseases in the Western Balkan countries. The secondary aim was to understand and compare the policies regarding prescribing-related competencies of family physicians. Methods: In June and July 2017, a document analysis was performed of national .positive medicines lists, strategic documents and clinical guidelines for the treatment of the most frequent non-communicable diseases; arterial hypertension, diabetes, hyperlipidemia, asthma and chronic obstructive pulmonary disease. All text phrases that referred to medicines prescribing were extracted and sorted into following domains: medicine availability, prescribing policy and medication prescribing - related competencies. Results: Possibilities for treatment of arterial hypertension, diabetes, hyperlipidemia, asthma and chronic obstructive pulmonary disease vary across the Western Balkan countries. This variance is reflected in the number of registered medicines, a number of parallels and number of different combinations, as well as restrictions placed on family physicians in prescribing insulin, inhaled corticosteroids, statins and angiotensin II receptor blockers (ARBs), without consultant’s recommendation. Conclusions: Western Balkan countries are capable of providing essential medicines for the treatment of NCDs, with full or partial reimbursement. There are some exceptions, related to statins, the new generation of oral antidiabetic agents and some of the antihypertensive combinations. Prescribing-related competencies of family physicians are limited. However, this practice is not compliant with the practices of family medicine, its principles, and primary care structures, and may potentially result in increased healthcare financial ramifications to both the system and patients due to frequent referrals to the specialists.
  • References (35)
  • Citations (1)
#1Sverre E. Kjeldsen (University of Oslo)H-Index: 84
#2Krzysztof Narkiewicz (Gdańsk Medical University)H-Index: 48
Last.Suzanne Oparil (UAB: University of Alabama at Birmingham)H-Index: 94
view all 4 authors...
#1Sven Streit (University of Bern)H-Index: 6
#2Marjolein Verschoor (University of Bern)H-Index: 2
Last.Kathryn Hoffmann (Medical University of Vienna)H-Index: 11
view all 38 authors...
#1Gregory A. Roth (UW: University of Washington)H-Index: 50
#2Catherine O. Johnson (UW: University of Washington)H-Index: 28
Last.Khurshid Alam (University of Melbourne)H-Index: 29
view all 171 authors...
#1Mihajlo Jakovljevic (University of Kragujevac)H-Index: 31
#2Jelena Arsenijevic (Maastricht University Medical Centre)H-Index: 6
Last.Wim Groot (Maastricht University Medical Centre)H-Index: 35
view all 6 authors...
#1Aleksandra Kovacevic (Military Medical Academy)H-Index: 5
#2Nemanja Rancic (Military Medical Academy)H-Index: 8
Last.Viktorija Dragojevic-Simic (Military Medical Academy)H-Index: 10
view all 4 authors...
#1Vanda Marković-Peković (Ministry of Health and Social Welfare)H-Index: 9
#2Ranko ŠkrbićH-Index: 7
Last.Ilse Truter (NMU: Nelson Mandela Metropolitan University)H-Index: 10
view all 11 authors...
View next paperChallenges for clinical practice and research in family medicine in reducing the risk of chronic diseases. Notes on the EGPRN Spring Conference 2017 in Riga